Aram A. Kitbalian

Aram A. Kitbalian

Auto-generated profile, based on publicly available information

Aram A. Kitbalian

Sechenov First Moscow State Medical University (Sechenov University); Lomonosov Moscow State University

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 November 2020 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
PGP. V. Glybochko
P. V. Glybochko
VFV. V. Fomin
V. V. Fomin
SMS. V. Moiseev
S. V. Moiseev
SASergey Avdeev
Sergey Avdeev
AYA. G. Yavorovskiy
A. G. Yavorovskiy
ЯАЯковлева Александра Андреевна
Яковлева Александра Андреевна
Aim. In a retrospective study, we evaluated factors associated with the early development of septic shock in patients with severe COVID-19. Materials and methods. We collected medical records of the intensive care unit patients submitted by the local COVID-19 hospitals across Russia to the Federal Center for the Critical Care at the Sechenov First Moscow State Medical University (Sechenov University). Septic shock in crticially ill patients requiring mechanical ventilation was defined as a need in vasopressors to maintain blood pressure. Results. We studied 1078 patients with severe COVID-19 who were admitted to the intensive care units for respiratory support. There were 611 males and 467 females. The mean age was 61.013.7 years. Five hundred twenty five medical records (48.7%) were received from the Moscow hospitals, 159 (14.7%) from the Moscow region, and 394 (36.5%) from the hospitals located in 58 regions of the Russian Federation. In 613 (56.9%) patients, diagnosis of SARS-CoV-2 infection was confirmed by PCR, and in the other cases it was established on the basis of the clinical picture and the results of the chest CT scan. Septic shock developed in 214 (19.9%) of 1078 patients. In the logistic regression model, the risk of septic shock in patients older than 50 years was higher than in patients of a younger age (OR 2.34; 95% CI 1.533.67; p0.0001). In patients with more severe SARS-CoV-2 infection, there was an increase in the prevalence of cardiovascular diseases, including coronary heart disease and atrial fibrillation, type 2 diabetes and malignant tumors. The risk of septic shock in patients with three or more concomitant diseases was higher than in patients without any concomitant chronic diseases (OR 1.76; 95% CI 1.762.70). Conclusion. The risk of septic shock in patients with acute respiratory distress syndrome induced by SARS-CoV-2 is higher in patients older than 50 years with concomitant diseases, although a severe course of the disease is also possible in younger patients without any concomitant disorders.

26 May 2022 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
LALarisa A. Akulkina
Larisa A. Akulkina
ASAnastasia Shchepalina
Anastasia Shchepalina
AKAram A. Kitbalian
Aram A. Kitbalian
PPPavel P. Potapov
Pavel P. Potapov
AMAlexey S. Moiseev
Alexey S. Moiseev
ЩАЩепалина Анастасия Александровна
Щепалина Анастасия Александровна
Treatment of patients with long-term persistent symptoms after COVID-19 is an urgent problem for clinicians around the world. One of the most significant manifestations of post-COVID-19 syndrome is organizing pneumonia that is usually treat with corticosteroids. The paper presents a clinical case of typical course of post-COVID-19 organizing pneumonia in a patient without previous lung disease. Risk factors, diagnostic methods and treatment options in this group of patients are also discuss.

4 August 2022 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
ASAnastasia Shchepalina
Anastasia Shchepalina
NCNatalia V. Chebotareva
Natalia V. Chebotareva
AKAram A. Kitbalian
Aram A. Kitbalian
PPPavel P. Potapov
Pavel P. Potapov
ANAnna A. Nartova
Anna A. Nartova
ЩАЩепалина Анастасия Александровна
Щепалина Анастасия Александровна
Aim. To determine the incidence and risk factors of acute kidney injury (AKI) in Russian cohort of patients with COVID-19. Materials and methods. We included 315 patients, who were hospitalized with COVID-19 from October 2020 till February 2021. The diagnosis was established on the basis of the positive SARS-CoV-2 swab test and/or typical radiologic findings on CT scans. Results. AKI complicated the clinical course in 92 (29.21%) cases. The independent risk factors of AKI were female sex, underline chronic kidney disease and the highest level of C-reactive protein during hospitalization. In the general group of patients were 41 (13%) lethal cases, in the group with AKI 32 (34.8%). Compared with those without AKI, patients with AKI had 4.065 (95% confidence interval 2.154 to 7.671) times the odds of death. Respiratory support, the highest serum creatinine and glucose levels appeared to be the risk factors of death among patients with AKI in the multivariable Cox regression. Conclusion. The clinical course of COVID-19 was complicated by AKI in 29% cases. The independent risk factors of AKI in patients with COVID-19 are underline chronic kidney disease, circulatory disorder and the highest level of C-reactive protein during hospitalization.

21 September 2022 in PULMONOLOGIYA
Verified
Journal Article
Open access
PDF file
LAL. A. Akulkina
L. A. Akulkina
MBM. Yu. Brovko
M. Yu. Brovko
ASAnastasia Shchepalina
Anastasia Shchepalina
VSVictoria Sholomova
Victoria Sholomova
AKA. A. Kitbalian
A. A. Kitbalian
SMSergey V. Moiseev
Sergey V. Moiseev
Interstitial lung diseases (ILDs) is a wide group of diffuse parenchymal lung diseases that can lead to interstitial pulmonary fibrosis. Clinical course of all ILDs, in particular with chronic fibrosing phenotype, can be complicated by an acute exacerbation caused by infection. Today, data about clinical course of COVID-19 in patients with progressive interstitial lung diseases is limited. In this case we described the course of COVID-19 infection in a patient with an interstitial pneumonia with autoimmune features (IPAF) and a progressive pulmonary fibrosis (PPF). We also discussed the typical features of COVID-19 in this population and the directions for further research.